How curcumin engages the NF-kB switch
Curcumin is the principal polyphenol in turmeric. In laboratory studies it interferes with the NF-kB pathway, a central controller of inflammatory gene expression. NF-kB normally sits inactive in the cytoplasm bound to an inhibitor; on an inflammatory signal the inhibitor is degraded and NF-kB enters the nucleus to switch on cytokine genes. Curcumin has been shown to blunt this activation in cell models, reducing the output of inflammatory cytokines.
Curcumin is a promiscuous molecule that touches many targets in vitro, so NF-kB is one of several proposed routes rather than a single clean mechanism.
The translation gap
A major caveat is bioavailability: orally, plain curcumin is poorly absorbed, rapidly metabolized, and quickly cleared, so the high concentrations used in cell studies are hard to reach in human tissue. Clinical trials show some signals in inflammatory conditions but are often small and use specially formulated extracts.
This is general educational information, not medical advice. Curcumin can interact with anticoagulants and other drugs, and inflammatory conditions should be managed with a qualified professional rather than self-treated with turmeric supplements.